Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
(Top holdings, as of January 16, 2025, below): Source: Amplify ETFs The Roundhill GLP-1 & Weight Loss ETF (OZEM) is another ETF in this segment, also launched in May 2024
The most commonly reported side effect is mild gastrointestinal discomfort, which is difficult to separate from the gastrointestinal effects of semaglutide itself
In simple terms, they are adhesive skin patches that claim to deliver ingredients linked in some way to GLP-1, a hormone involved in appetite and glucose regulation
Patients are encouraged to report any suspected reactions at yellowcard.mhra.gov.uk
US$ 25.19
US$ 21.27
US$ 24.45
US$ 23.24
US$ 25.12
US$ 29.19
US$ 20.14
US$ 26.96
US$ 26.14
US$ 28.13
